Tag Archives: AbbVie
By Pharm Exec | Published: February 28, 2014
While biosimilar products have been launched in Asia and Europe, they are at least three years away in the US, according to a new report on the global biosimilar drugs market.
By Reflector | Published: October 16, 2013
Who is Trying to Stop the European Transparency Bandwagon? Reflector, EPE, October 14 2013 The data-transparency bandwagon is rolling rapidly across Europe, energetically propelled by regulators, health campaigners, and generic manufacturers. Much of the research-based industry is stepping out of the way of what looks like an unstoppable juggernaut, hoping at best to nudge it […]